Dynavax Technologies
DVAX
#5481
Rank
$1.29 B
Marketcap
$10.99
Share price
0.25%
Change (1 day)
-14.76%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: $1.29 Billion USD

As of December 2025 Dynavax Technologies has a market cap of $1.29 Billion USD. This makes Dynavax Technologies the world's 5481th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025$1.29 B-24.5%
2024$1.70 B-5.43%
2023$1.80 B33.12%
2022$1.35 B-19.57%
2021$1.68 B244.19%
2020$0.49 B2.21%
2019$0.47 B-16.59%
2018$0.57 B-49.24%
2017$1.13 B644.59%
2016$0.15 B-83.62%
2015$0.92 B109.42%
2014$0.44 B-13.89%
2013$0.51 B-1.13%
2012$0.52 B23.74%
2011$0.42 B13.8%
2010$0.36 B379.99%
2009$77.07 M130.23%
2008$33.47 M-83.52%
2007$0.20 B-44.27%
2006$0.36 B265.8%
2005$99.66 M-47.38%
2004$0.18 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Dynavax Technologies was reported to be:

$1.28 Billion USD
by Nasdaq info icon info icon
$1.28 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
$0.13 B-89.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$26.80 B 1,977.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$250.24 B 19,296.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$150.77 B 11,586.77%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$279.64 B 21,575.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
$97.42 B 7,451.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
$148.20 B 11,387.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$32.69 B 2,434.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
$178.46 B 13,732.98%๐Ÿ‡บ๐Ÿ‡ธ USA